Deepti Chopra

458 total citations
19 papers, 295 citations indexed

About

Deepti Chopra is a scholar working on Toxicology, Molecular Biology and Pharmacology. According to data from OpenAlex, Deepti Chopra has authored 19 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Toxicology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Deepti Chopra's work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Antibiotic Use and Resistance (3 papers) and Drug-Induced Adverse Reactions (2 papers). Deepti Chopra is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (4 papers), Antibiotic Use and Resistance (3 papers) and Drug-Induced Adverse Reactions (2 papers). Deepti Chopra collaborates with scholars based in India and Romania. Deepti Chopra's co-authors include Shridhar Dwivedi, Harmeet Singh Rehan, Vibha Sharma, Bharti Bhandari, Mridu Dudeja, Satinder Aneja, Suvasini Sharma, Nidhi Singh, Vandna Kukshal and Ravishankar Ramachandran and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Traditional and Complementary Medicine.

In The Last Decade

Deepti Chopra

17 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepti Chopra India 8 62 49 46 41 31 19 295
C.D. Tripathi India 9 28 0.5× 40 0.8× 39 0.8× 92 2.2× 27 0.9× 17 386
Anjan Adhikari India 9 40 0.6× 31 0.6× 52 1.1× 15 0.4× 45 1.5× 68 373
Umar Yagoub Saudi Arabia 10 58 0.9× 24 0.5× 14 0.3× 54 1.3× 11 0.4× 17 332
Niti Mittal India 12 14 0.2× 25 0.5× 29 0.6× 37 0.9× 23 0.7× 50 390
Xianmei Zhou China 16 48 0.8× 158 3.2× 18 0.4× 11 0.3× 41 1.3× 48 670
Melisa Intan Barliana Indonesia 15 20 0.3× 132 2.7× 44 1.0× 11 0.3× 67 2.2× 95 559
Thaís Teles de Souza Brazil 8 42 0.7× 31 0.6× 17 0.4× 17 0.4× 70 2.3× 25 349
Ayşe Gelal Türkiye 10 18 0.3× 62 1.3× 22 0.5× 21 0.5× 23 0.7× 50 327
Mulugeta Molla Ethiopia 11 21 0.3× 34 0.7× 25 0.5× 7 0.2× 47 1.5× 32 261
Anna Wiela−Hojeńska Poland 12 17 0.3× 72 1.5× 36 0.8× 8 0.2× 17 0.5× 42 416

Countries citing papers authored by Deepti Chopra

Since Specialization
Citations

This map shows the geographic impact of Deepti Chopra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepti Chopra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepti Chopra more than expected).

Fields of papers citing papers by Deepti Chopra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepti Chopra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepti Chopra. The network helps show where Deepti Chopra may publish in the future.

Co-authorship network of co-authors of Deepti Chopra

This figure shows the co-authorship network connecting the top 25 collaborators of Deepti Chopra. A scholar is included among the top collaborators of Deepti Chopra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepti Chopra. Deepti Chopra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chopra, Deepti, et al.. (2022). Adverse Drug Reactions in Corona Virus Disease Patients Admitted to IntensiveCare Unit: An Observational Study. Current Drug Safety. 18(2). 202–206. 1 indexed citations
2.
Chopra, Deepti, Bharti Bhandari, & Shridhar Dwivedi. (2021). Beneficial role of Indian medicinal plants in COVID-19. SHILAP Revista de lepidopterología. 8(2). 166–170. 2 indexed citations
3.
Chopra, Deepti, et al.. (2021). Prevalence of self-reported anxiety and self-medication among upper and middle socioeconomic strata amidst COVID-19 pandemic. Journal of Education and Health Promotion. 10(1). 73–73. 14 indexed citations
4.
Bhandari, Bharti, et al.. (2021). Online teaching and learning during COVID era: Medical students’ feedback and their perspectives. Journal of Punjab Academy of Forensic Medicine & Toxicology. 21(2). 21–26. 1 indexed citations
5.
Chopra, Deepti, et al.. (2020). Toxicity of organic solvent in a young painter presenting as transient hepatitis: A case report. Indian Journal of Occupational and Environmental Medicine. 24(1). 33–33.
6.
Chopra, Deepti, Jaspreet Kaur Boparai, Bharti Bhandari, Anurag Srivastava, & Rakesh Gupta. (2020). Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs. Infectious Disorders - Drug Targets. 21(7). e160921189260–e160921189260. 3 indexed citations
7.
Chopra, Deepti, et al.. (2019). Adverse Drug Reactions of Anti-Epileptic Drugs in Children with Epilepsy: A Cross-Sectional Study. Current Drug Safety. 14(3). 217–224. 17 indexed citations
8.
Chopra, Deepti, et al.. (2019). Generalized seizure following lignocaine administration: Case report and literature review. SHILAP Revista de lepidopterología. 8(10). 3440–3440. 4 indexed citations
10.
Chopra, Deepti, et al.. (2018). Antimicrobial Susceptibility Patterns of an Emerging Multidrug Resistant Nosocomial Pathogen: Acinetobacter baumannii. Malaysian Journal of Medical Sciences. 25(3). 129–134. 25 indexed citations
11.
Chopra, Deepti, et al.. (2018). Pharmacoepidemiological observational study of antimicrobial use in outpatients of ophthalmology department in North Indian population. Journal of Pharmacy And Bioallied Sciences. 10(2). 72–72. 4 indexed citations
12.
Chopra, Deepti & Bharti Bhandari. (2018). Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?. Infectious Disorders - Drug Targets. 20(1). 2–15. 7 indexed citations
13.
Chopra, Deepti, et al.. (2016). Chemotherapy-induced adverse drug reactions in oncology patients: A prospective observational survey. Indian Journal of Medical and Paediatric Oncology. 37(1). 42–46. 90 indexed citations
14.
Chopra, Deepti, et al.. (2015). Galactorrhoea:Report of Two Cases.. PubMed. 10(2). 136–139. 5 indexed citations
15.
Dwivedi, Shridhar, et al.. (2014). Anaphylaxis following intravenous ranitidine: A rare adverse reaction of a common drug. Indian Journal of Pharmacology. 46(2). 234–234. 9 indexed citations
16.
Dwivedi, Shridhar & Deepti Chopra. (2014). Revisiting Terminalia arjuna – An Ancient Cardiovascular Drug. Journal of Traditional and Complementary Medicine. 4(4). 224–231. 87 indexed citations
17.
Bhandari, Bharti, et al.. (2013). Pharmacological effects of Tribulus Terrestris: A Review. 1(1). 71–71. 9 indexed citations
18.
Kukshal, Vandna, et al.. (2012). M. tuberculosis Sliding β-Clamp Does Not Interact Directly with the NAD+ -Dependent DNA Ligase. PLoS ONE. 7(4). e35702–e35702. 16 indexed citations
19.
Rehan, Harmeet Singh & Deepti Chopra. (2009). Guide to reporting adverse drug reactions. International Journal of Risk & Safety in Medicine. 21(4). 229–234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026